To include your compound in the COVID-19 Resource Center, submit it here.

NGR-hTNF: Additional Phase II data

Additional data from the open-label, Italian Phase II NGR007 trial in 28 patients showed that

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE